首页> 外国专利> Methods for treating diabetes by administering a Glucagon Receptor Antagonist in combination with a cholesterol Absorption Inhibitor, Combination

Methods for treating diabetes by administering a Glucagon Receptor Antagonist in combination with a cholesterol Absorption Inhibitor, Combination

机译:通过将胰高血糖素受体拮抗剂与胆固醇吸收抑制剂联合使用来治疗糖尿病的方法

摘要

Use of a Glucagon Receptor Antagonist in combination with a cholesterol Absorption Inhibitor for the treatment of Diabetes and Related Conditions.Claim 1: a method to treat diabetes in a subject comprising administering to said Mammal Mammal subject: (a) a Glucagon Receptor Antagonist, and (b) a cholesterol Absorption Inhibitor; in which the subject Mammal has a level of LDL Cholesterol in plasma Less than 130 mg / dl.Claim 8: any method of claims 1 - 7 in which the compound inhibitor of cholesterol Absorption is formula (1) or a pharmaceutically acceptable Salt thereof.Claim 9: any method of claims 1 - 8 in the Glucagon Receptor Antagonist Compound is a compound selected from compounds (Table 2); or a pharmaceutically acceptable Salt of the same.
机译:胰高血糖素受体拮抗剂与胆固醇吸收抑制剂的组合在治疗糖尿病和相关病症中的用途。权利要求1:一种在受试者中治疗糖尿病的方法,其包括向所述哺乳动物受试者施用:(a)胰高血糖素受体拮抗剂,和(b)胆固醇吸收抑制剂; 8.根据权利要求1至7中任一项所述的方法,其中所述胆固醇吸收的化合物抑制剂为式(1)或其药学上可接受的盐,其中所述受试者的哺乳动物的血浆中LDL胆固醇的水平小于130mg / dl。 9.权利要求1-8中任一项的方法,其中胰高血糖素受体拮抗剂化合物是选自化合物的化合物(表2);或其药学上可接受的盐。

著录项

  • 公开/公告号AR093851A1

    专利类型

  • 公开/公告日2015-06-24

    原文格式PDF

  • 申请/专利权人 MERCK SHARP & DOHME CORP.;

    申请/专利号AR2013P104555

  • 发明设计人

    申请日2013-12-06

  • 分类号A61K31/397;A61K31/165;A61K31/404;A61K31/415;A61K31/435;A61P3/10;

  • 国家 AR

  • 入库时间 2022-08-21 15:16:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号